<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01860911</url>
  </required_header>
  <id_info>
    <org_study_id>12-005173</org_study_id>
    <nct_id>NCT01860911</nct_id>
  </id_info>
  <brief_title>Plasma Triglyceride Extraction by The Muscle</brief_title>
  <official_title>Regulation of the Plasma Triglyceride Extraction in Muscle in Insulin Resistance</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>American Diabetes Association</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Increased accumulation of fat into the muscles is associated with what is called&#xD;
      insulin-resistant state, which is a pre-diabetic state. The purpose of this research is to&#xD;
      find out how fat circulating in the blood following fat consumption is taken up by the&#xD;
      muscles in healthy people as well as people that are insulin-resistant. The investigators are&#xD;
      specifically interested in how a hormone called insulin is involved in this process. Findings&#xD;
      from this research will contribute to our understanding of why insulin-resistant people have&#xD;
      increased accumulation of fat in their muscles, and ultimately help to design appropriate&#xD;
      interventions to prevent type 2 Diabetes.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 2013</start_date>
  <completion_date type="Actual">August 31, 2016</completion_date>
  <primary_completion_date type="Actual">August 31, 2016</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Triglyceride extraction across the forearm</measure>
    <time_frame>Measured during a 7-hour infusion study</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Muscle microvascular blood volume</measure>
    <time_frame>Selected 15-minute periods during the 7 hour infusion study</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">33</enrollment>
  <condition>Obesity</condition>
  <condition>Insulin Resistance</condition>
  <arm_group>
    <arm_group_label>Insulin-Sensitive</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>One group consists of insulin sensitive volunteers.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Insulin-Resistant</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>One group consists of insulin resistant volunteers.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Insulin</intervention_name>
    <arm_group_label>Insulin-Resistant</arm_group_label>
    <arm_group_label>Insulin-Sensitive</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>NG-monomethyl-L-arginine</intervention_name>
    <arm_group_label>Insulin-Sensitive</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Body mass index (BMI): &lt; 25 kg/m2 or &gt; 30 kg/m2;&#xD;
&#xD;
          -  Insulin sensitivity index (ISI): insulin-sensitive ISI ≥ 7, insulin-resistant ISI ≤ 5.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Medication or supplements known to affect either endothelial function or lipid&#xD;
             metabolism (i.e. arginine, protein, fish oil)&#xD;
&#xD;
          -  Acute illness&#xD;
&#xD;
          -  Uncontrolled metabolic disease, including liver or renal disease&#xD;
&#xD;
          -  Atrial fibrillation, history of syncope, limiting or unstable angina, congestive heart&#xD;
             failure, known or suspected right-to-left, bi-directional or transient right-to-left&#xD;
             cardiac shunts&#xD;
&#xD;
          -  Cardiac pacemaker or other medical device implanted in the body&#xD;
&#xD;
          -  Pulmonary hypertension or other unstable cardiopulmonary conditions&#xD;
&#xD;
          -  ECG documented abnormalities or valvular disease&#xD;
&#xD;
          -  Low hemoglobin or hematocrit (i.e., lower than accepted laboratory values)&#xD;
&#xD;
          -  History of hypertension or elevated blood pressure (systolic, &gt;140 mmHg or a&#xD;
             diastolic, &gt;95 mmHg)&#xD;
&#xD;
          -  History of hyperlipidemia or plasma triglyceride concentration &gt;200 mg/dl&#xD;
&#xD;
          -  Diagnosed diabetes, or 2-h plasma glucose &gt;200 mg/dl during an oral glucose tolerance&#xD;
             test&#xD;
&#xD;
          -  Current participation in a weight-loss regimen, including extreme dietary practices&#xD;
&#xD;
          -  Use of anabolic steroids or corticosteroids (within 3 months)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lori Roust, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Christos S Katsanos, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Arizona State University/Mayo Clinic Arizona</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mayo Clinic in Arizona</name>
      <address>
        <city>Scottsdale</city>
        <state>Arizona</state>
        <zip>85259</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.mayo.edu/research/clinical-trials</url>
    <description>Mayo Clinic Clinical Trials</description>
  </link>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>May 21, 2013</study_first_submitted>
  <study_first_submitted_qc>May 22, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 23, 2013</study_first_posted>
  <last_update_submitted>October 1, 2021</last_update_submitted>
  <last_update_submitted_qc>October 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Lori R. Roust</investigator_full_name>
    <investigator_title>PI</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin Resistance</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>omega-N-Methylarginine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

